EcoDrugPlus

Leukotriene B4 Receptor

Ensembl ID : ENSDARG00000032631
Gene Symbol: LTB4R
8 Enzyme and pathways 5 Cross references
143 Possible Orthologues:

Leukotriene B4 Receptor 2a

Ensembl ID : ENSDARG00000088615
Gene Symbol: LTB4R2A
8 Enzyme and pathways 5 Cross references
156 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSDARG00000054170
Gene Symbol: LTB4R2B
8 Enzyme and pathways 5 Cross references
167 Possible Orthologues:

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSDARG00000060679
Gene Symbol: KDM1A
13 Enzyme and pathways 5 Cross references
214 Possible Orthologues:

Lysyl Oxidase-Like 2a

Ensembl ID : ENSDARG00000044010
Gene Symbol: LOXL2A
5 Cross references
210 Possible Orthologues:

Lysyl Oxidase-Like 2b

Ensembl ID : ENSDARG00000044074
Gene Symbol: LOXL2B
5 Enzyme and pathways 5 Cross references
213 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSDARG00000071336
Gene Symbol: MIF
5 Enzyme and pathways 5 Cross references
235 Possible Orthologues:

Macrophage Stimulating 1 Receptor A

Ensembl ID : ENSDARG00000060235
Gene Symbol: MST1RA
5 Cross references
196 Possible Orthologues:

Macrophage Stimulating 1 Receptor B

Ensembl ID : ENSDARG00000004871
Gene Symbol: MST1RB
3 Enzyme and pathways 5 Cross references
194 Possible Orthologues:

Matrix Metallopeptidase 13a

Ensembl ID : ENSDARG00000012395
Gene Symbol: MMP13A
5 Cross references
303 Possible Orthologues:

Matrix Metallopeptidase 13a

Ensembl ID : ENSDARG00000114451
Gene Symbol: MMP13A
3 Cross references
303 Possible Orthologues:

Matrix Metallopeptidase 14a (Membrane-Inserted)

Ensembl ID : ENSDARG00000002235
Gene Symbol: MMP14A
4 Enzyme and pathways 5 Cross references
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).